David Herrmann, MD, Neurology, Rochester, NY, Highland Hospital

DavidNHerrmannMD

Neurology Rochester, NY

Neuromuscular Medicine, Neurophysiology, Neurooncology

Professor, Neurology, Chief, Neuromuscular Division, University of Rochester School of Medicine & Dentistry

Dr. Herrmann is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Herrmann's full profile

Already have an account?

Education & Training

  • University of Michigan Hospitals and Health Centers
    University of Michigan Hospitals and Health CentersFellowship, Clinical Neurophysiology, 1998 - 1999
  • University of Michigan Hospitals and Health Centers
    University of Michigan Hospitals and Health CentersResidency, Neurology, 1995 - 1998
  • University of the Witwatersrand
    University of the WitwatersrandClass of 1989

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2014 - 2015
  • NY State Medical License
    NY State Medical License 1999 - 2022
  • MI State Medical License
    MI State Medical License 1994 - 2001
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Clinical Neurophysiology
  • American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Peripheral Sensory Pathology Seen in Autism Spectrum Disorder
    Peripheral Sensory Pathology Seen in Autism Spectrum DisorderOctober 15th, 2020
  • Regenacy Pharmaceuticals Announces Collaboration with the Charcot-Marie-Tooth Association (CMTA) to Advance Ricolinostat for the Treatment of Hereditary Neuropathy
    Regenacy Pharmaceuticals Announces Collaboration with the Charcot-Marie-Tooth Association (CMTA) to Advance Ricolinostat for the Treatment of Hereditary NeuropathyAugust 2nd, 2018
  • CMT1A Patients Needed for Study Seeking New Ways to Monitor Disease Progression
    CMT1A Patients Needed for Study Seeking New Ways to Monitor Disease ProgressionSeptember 16th, 2020

Grant Support

  • In-Vivo Confocal Imaging Of Meissner'S Corpuscles As A Measure Of HIV NeuropathyNational Institute Of Neurological Disorders And Stroke2007–2008
  • Epidermal Innervation As An Outcome MeasureNational Institute Of Neurological Disorders And Stroke2002–2006

Hospital Affiliations